ARCHIVES

Clinical Trials: Phase I Trial of Karenitecin Begins, BioNumerik Says

This article is from The Cancer Letter archive.

Vol. 25 No. 09 | March 5, 1999

Download PDF Visit The Full Archive

Related Articles

CMS Final Rule Imposes 6 Percent Cut On Physician Fees Over Four Years

November 6, 2009

CCOP Recompetition Approved By NCAB

May 23, 1986

Rescission Cuts $5-6 Mil. From NCI FY94 Appropriations , Affects Intramural Program

March 11, 1994

DCT Board Insists On Being Heard In Development Of CCOP Guidelines

February 19, 1982

Parkinson Heads Oncology At Amgen

May 2, 2003

In Brief: Three Centers Win Comprehensive Designation; Hiatt Named Deputy Director, NCI Cancer Control

October 31, 1997